(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADAPTIMMUNEASSIST

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ADAPTIMMUNEASSIST

ST13

US500000098391186

Class

5, 44

Filing

98391186

Registration

7650921

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

12/10/2025

Trademark type

Combined

Nice classes

5, 44

Filing date

02/05/2024

Registration date

01/14/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/14/2025

Last transaction

12/10/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

16

Owner location

LOUISVILLE, KY

Examiner

SOLANO,CARLITA JAYE

Law office

O10

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the term "ADAPTIMMUNEASSIST" with bubbles in various sizes forming an arch over the term with the last letter "T" in a stylized form.

Holders and representatives

Holders

USWM CT, LLC
Adaptimmune Limited

Representatives

Amy B. Berge Gray Ice Higdon, PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cell therapy pharmaceutical preparations; immunotherapy preparations for use in cancer treatment and treatment of autoimmune diseases; Tcell receptors in the nature of pharmaceutical preparations for use in cancer treatment and treatment of autoimmune diseases; pharmaceutical immunotherapy preparations comprising engineered T-cell receptors for use in cancer treatment and treatment of autoimmune diseases; pharmaceutical immunotherapy preparations comprising genes encoding engineered T-cell receptors for use in cancer treatment and treatment of autoimmune diseases

Class 44

Cell therapy medical treatment services; medical servicesimmunotherapy services; medical servicesmedical treatment and immunetherapy comprising harvesting a patient's white blood cellscombining white blood cells with an engineered T-cell receptor therapeutictransducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient

Publications

History of USPTO decisions and trademark events.

28 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/08/2025

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

12/08/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/08/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/08/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/08/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/08/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/03/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/26/2024

PUBO

PUBLISHED FOR OPPOSITION

11/26/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/20/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/31/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

10/31/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/31/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

10/31/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/31/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/23/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/23/2024

ALIE

ASSIGNED TO LIE

10/23/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/15/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/12/2024

GNRT

NON-FINAL ACTION E-MAILED

06/12/2024

CNRT

NON-FINAL ACTION WRITTEN

06/12/2024

DOCK

ASSIGNED TO EXAMINER

06/10/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/02/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/02/2024

NWAP

NEW APPLICATION ENTERED

02/05/2024

Continuous trademark protection

Get notified about every new filing that threatens ADAPTIMMUNEASSIST or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.